Celgene Corp $88.94

up +1.21


30/7/2014 01:31 PM  |  NASDAQ : CELG  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get CELG Trend Analysis - it has underperformed the S&P 500 by 55%

Partner Headlines

  1. Biotechs Fall Despite Beats

    IBD
  2. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  3. Thursday Morning Earnings Reports

    Benzinga
  4. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  5. Stocks Up And Down At Open; Under Armour, Facebook Surge

    IBD
  6. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  7. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  8. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  9. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  10. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  11. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  12. Biogen Shares Rebound As Street Has A Change Of Heart

    IBD
  13. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  14. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  15. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  16. UPDATE: Morgan Stanley Reiterates On Celgene As EU Patents Risk May Be ...

    Benzinga
  17. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  18. Stocks Close Higher As Biotech, Internet Stocks Gain

    IBD
  19. Celgene's Otezla fails trial

    IBD
  20. Two Analysts Don't See Celgene's Weak Trial Results As A Huge Setback

    Benzinga
  21. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  22. Celgene Slips; Drug Candidate Fails Phase III Trial Endpoint

    Benzinga
  23. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  24. Spectrum lymphoma drug OK'd

    IBD
  25. Spectrum Pharma Lymphoma Drug Approved Early

    IBD
  26. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  27. Chipotle, Keurig Near Buy Points; Energy Dominates

    IBD
  28. Markets Little Changed As The Quarter Comes To An End

    Benzinga
  29. Stocks Mildly Higher To End The Week

    Benzinga
  30. Celgene Board Member Rodman Drake Dies

    Benzinga
  31. Celgene, Chipotle, Keurig Remain In Buying Range

    IBD
  32. Stocks Poised For Soft Start; Micros Systems Surges Premarket

    IBD
  33. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  34. Stocks Hold Slim Gains; Celgene, Salix Rally

    IBD
  35. Credit Suisse Views Celgene As 'Underappreciated'

    Benzinga
  36. Market Wrap For June 19: Stocks Little Changed, Gold and Silver Higher

    Benzinga
  37. Stocks On Track To End Win Streak; Oracle Reports After Close

    IBD
  38. Stocks Stage Tightly Mixed Open; Kroger, Celgene, BitAuto Gain

    IBD
  39. UPDATE: Morgan Stanley Reiterates On Celgene On AG-221 Potential

    Benzinga
  40. UPDATE: Morgan Stanley Reiterates On Celgene Ahead Of Markman Hearing

    Benzinga
  41. Investor's Corner: How To Use The Big Cap 20

    IBD
  42. Biggest Post-Crisis Stock Buyback By IBM

    YCharts
  43. Market Wrap For April 25: Markets Finish The Week In Negative Territory

    Benzinga
  44. Alexion Tops, Celgene Mixed

    IBD
  45. Alexion, Celgene Report Contrasting Q1 Earnings

    IBD
  46. Celgene Announces Agreement with Nogra Pharma Limited to Develop, Commercialize ...

    Benzinga
  47. Earnings Scheduled For April 24, 2014

    Benzinga
  48. Ken Fisher's Top Increases of the First Quarter

    GuruFocus
  49. A Drill Can Help Identify Right Time To Sell Leaders

    IBD
  50. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
Trading Center